InvestorsHub Logo
Followers 134
Posts 2743
Boards Moderated 0
Alias Born 03/12/2010

Re: None

Sunday, 04/04/2021 1:52:06 PM

Sunday, April 04, 2021 1:52:06 PM

Post# of 30377
ALTO Form 10-K highlights Filed 03/26/21 for the Period Ending 12/31/20:

link to 10-K

*Net sales were $168.8 million, compared to $357.6 million.

*Cost of goods sold was $155.2 million, compared to $354.4 million.

*Gross profit was $13.6 million, compared to $3.2 million.

*Selling, general and administrative expenses were $6.7 million, compared to $11.8 million.

*Operating loss was $14.2 million, compared to $37.9 million.

*Net loss available to common stockholders was $20.5 million, or $0.30 per share, and included an impairment charge of $24.4 million related to thecompany’s Western assets. This compares to a loss of *$41.4 million, or $0.85 per share, for the three months ended December 31, 2019.

*Adjusted EBITDA was $16.4 million, compared to $1.9 million.

My opinions and comments are just that. They are not a recommendation to either buy or sell any security.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ALTO News